About Us

In 1994 Ron Evason founded the Prostate Cancer Foundation of Canada. Diagnosed with prostate cancer in 1993, he realized that there was little, if any, high caliber research being done for the disease. The Foundation’s mission was to support research into the cause, cure, and prevention of prostate cancer.

The Foundation worked tirelessly with professionals and organizations to advance the prostate cancer cause. A 1997 National Prostate Cancer Forum brought together 150 stakeholders to develop direction for future research, communication, and advocacy activities. The Foundation continued to move forward on forum recommendations by participating in the Prostate Cancer Alliance of Canada.

In July 1999, the Foundation merged with the Canadian Prostate Cancer Research Fund, to become the Prostate Cancer Research Foundation of Canada. Since then, the Foundation has become one of Canada's foremost organizations dedicated solely to raising funds for research to eliminate prostate cancer.

In May 2009, after ten years of successful fundraising and research efforts, the Foundation re-branded itself from the Prostate Cancer Research Foundation of Canada to Prostate Cancer Canada

VISION

Prostate Cancer Canada’s vision is to be a global leader in the fight against prostate cancer, earning the enthusiasm and support of Canadians through integrity, compassion, and innovation.

MISSION

Prostate Cancer Canada is the leading national foundation dedicated to the elimination of the most common cancer in men through research, advocacy, education, support and awareness.

KEY MESSAGES

  • Prostate Cancer Canada invests the generous donations of Canadians towards funding research that will uncover better diagnostic and treatment options, and towards providing comprehensive education and support services for those living with and affected by prostate cancer.
  • Prostate Cancer is the most common cancer in men; 1 in 7 Canadian men will be diagnosed with prostate cancer in their lifetime.
  • 21,300 expected new cases in 2017.
  • 4,100 estimated deaths in 2017.  
  • Early detection saves lives. When detected early, the survival rate for prostate cancer is close to 100%.  
  • Men and their families are encouraged to initiate a shared decision-making process with their doctors regarding prostate cancer.  
  • In agreement with prostate cancer experts, Prostate Cancer Canada recommends that men talk to their health care professional about the benefits and risks of testing for prostate cancer using the PSA test. Risk factors for prostate cancer include age, family history and being of black ethnicity.
  • The PSA test is a simple blood test which measures the amount of prostate specific antigen (PSA) in your blood.

Donate Now!




Subscribe to our free monthly e-newsletter!

* indicates required

 





 
PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  
More

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.
More

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.
More


Click here for news archive